• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Characterization of the M2e antibody response following highly pathogenic H5N1 avian influenza virus infection and reliability of M2e ELISA for identi

tetano

Editor, Senior Moderator
Avian Pathol. 2015 Apr 27:1-40. [Epub ahead of print]
[h=1]Characterization of the M2e antibody response following highly pathogenic H5N1 avian influenza virus infection and reliability of M2e ELISA for identifying infected among vaccinated chickens.[/h] Tarigan S[SUP]1[/SUP], Indriani R, Durr PA, Ignjatovic J.
[h=3]Author information[/h]

[h=3]Abstract[/h] A surveillance method able to differentiate between vaccinated and infected animals (DIVA) is required for those countries that practice vaccination against highly pathogenic avian influenza (HPAI) H5N1. The M2e protein of influenza virus is a potentially useful DIVA antigen but little is known about the M2e antibody response and factors influencing its detection. In this study, the M2e antibody response was characterised in layer birds vaccinated and challenged with an Indonesian H5N1 virus isolate, using a single M2e peptide (sp-M2e) or four-branched-multiple-antigenic form of M2e (MAP-M2e) as antigens in two separate ELISAs. Anti-M2e antibodies were absent in chicks with high level of maternal haemagglutination inhibition (HI) antibodies and also in all layers vaccinated once, twice or three times with an inactivated commercial H5N1 vaccine. In contrast, anti-M2e antibodies were detected in vaccinated layers challenged with H5N1 virus and their presence was associated with virus isolation and an increase in HI titres. The number of birds that developed M2e antibodies, as well as the strength and duration of the M2e antibody response were strongly influenced by the length of the interval between vaccination and challenge. Birds challenged at six weeks after vaccination all developed M2e antibodies by 14 days that lasted until at least 56 days after infection. In birds challenged at two weeks after vaccination only a proportion of birds developed M2e antibodies by 14 days that lasted only until 28 days post infection. Both sp-M2e and MAP-M2e ELISAs had high diagnostic specificity but the diagnostic sensitivity of MAP-M2e ELISA was significantly higher and more effective in detecting M2e antibody in immune and infected birds. The results show that MAP-M2e ELISA would be useful for surveillance in countries using vaccination to control HPAI H5N1.


PMID: 25915110 [PubMed - as supplied by publisher]
 
Back
Top Bottom